FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Cannabinoids

  • Home
  •  | 
  • Tag Archives: "Cannabinoids"

Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments

Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments
Research will be led by Technion faculty members Dr. David "Dedi" Meiri, Head, Laboratory of Cancer Biology and Cannabinoid Research and Dr. Yaron Fuchs, Head, Laboratory of Cancer Biology and Cannabinoid Research, two of the world's leading researchers in cannabis and skin stem cell research, respectively. Dr. Meiri heads the Laboratory of Cannabis and Cancer Research with vast experience in cannabis and endocannabinoid research. Dr. Fuchs heads the Laboratory of Stem Cell Biology and Regenerative Medicine with years of experience in the biology of the skin and its pathologies. Development and implementation of the research will be conducted at Technion's Laboratory of Cancer Biology and Cannabis Research and the Lorry I. Lokey Interdisciplinary Center of Life Sciences and Engineering in Haifa, Israel.
Read more

Atlas Growers™ Receives Cultivation and Production Licenses from Health Canada

Atlas Growers™ Receives Cultivation and Production Licenses from Health Canada
EDMONTON, Alberta, Oct. 15, 2018 (GLOBE NEWSWIRE) -- ATLAS GROWERS LTD. (“Atlas” or the “Company”), a wholly owned subsidiary of Atlas Biotechnologies Inc., is pleased to announce that it has received its Cultivation and Production licenses for its phase 1, 38,000 square foot production Facility from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). With this licensing, Atlas will be able to produce dried cannabis, cannabis oil, cannabis resin, fresh cannabis, cannabis plants and cannabis seeds. Atlas’ purpose-built facility has an estimated production capacity of over 5,000 kg per year and utilizes cutting edge cultivation technology designed and overseen by esteemed Mr. Jim Hole, VP Cultivation for Atlas.
Read more

SugarBud Provides Operations Update

SugarBud Provides Operations Update
CALGARY, Alberta, Oct. 10, 2018 (GLOBE NEWSWIRE) -- SugarBud Craft Growers Corp. (“SugarBud” or the “Company”) (trading as Relentless Resources Ltd.) is pleased to provide an operations update regarding its state-of-the-art vertical cannabis cultivation facility at Stavely, Alberta (the “Facility”). The Company is also pleased to announce that it has filed a filing statement (the “Filing Statement”) under SugarBud’s profile on SEDAR at www.sedar.com with respect to the Company’s planned “Change of Business” pursuant to the policies of the TSX Venture Exchange (“TSXV”).
Read more

Radient Technologies Inc. receives Controlled Drugs and Substances Licence for its Manufacturing Facility

Radient Technologies Inc. receives Controlled Drugs and Substances Licence for its Manufacturing Facility
EDMONTON, Alberta, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) is pleased to announce that it has received its Controlled Drugs and Substances Licence, also known as a Dealer’s Licence (the “Licence”), from Health Canada’s Office of Controlled Substances for its Manufacturing Facility located at 4035 – 101 NW Street, Edmonton, Alberta.  
Read more